147 related articles for article (PubMed ID: 30688413)
21. Clinicopathological study on para-aortic lymph node metastasis without pelvic lymph node metastasis in endometrial cancer.
Tomisato S; Yamagami W; Susumu N; Kuwahata M; Takigawa A; Nomura H; Kataoka F; Hirasawa A; Banno K; Aoki D
J Obstet Gynaecol Res; 2014 Jun; 40(6):1733-9. PubMed ID: 24888941
[TBL] [Abstract][Full Text] [Related]
22. The prediction of para-aortic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
Numanoglu C; Corbacioglu Esmer A; Ulker V; Goksedef BP; Han A; Akbayir O; Guraslan B
J Obstet Gynaecol; 2014 Feb; 34(2):177-81. PubMed ID: 24456443
[TBL] [Abstract][Full Text] [Related]
23. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
[TBL] [Abstract][Full Text] [Related]
24. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
Menderes G; Azodi M; Schwartz P; Silasi DA
Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
[TBL] [Abstract][Full Text] [Related]
25. Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancer.
Fotopoulou C; El-Balat A; du Bois A; Sehouli J; Harter P; Muallem MZ; Krätschell RW; Traut A; Heitz F
Arch Gynecol Obstet; 2015 Dec; 292(6):1321-7. PubMed ID: 25990476
[TBL] [Abstract][Full Text] [Related]
26. Ultrastaging of para-aortic lymph nodes in stage IIIC1 endometrial cancer: a preliminary report.
Todo Y; Suzuki Y; Azuma M; Hatanaka Y; Konno Y; Watari H; Kato H; Matsuno Y; Yamashiro K; Sakuragi N
Gynecol Oncol; 2012 Dec; 127(3):532-7. PubMed ID: 22940490
[TBL] [Abstract][Full Text] [Related]
27. Pelvic lymphangioleiomyomatosis treated successfully with everolimus: Two case reports with literature review.
Wahid S; Chiang PC; Luo HL; Huang SC; Tsai EM; Chiang PH
Medicine (Baltimore); 2017 Mar; 96(10):e4562. PubMed ID: 28272193
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
29. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer.
Mariani A; Webb MJ; Keeney GL; Podratz KC
Gynecol Oncol; 2001 Apr; 81(1):100-4. PubMed ID: 11277658
[TBL] [Abstract][Full Text] [Related]
30. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
[TBL] [Abstract][Full Text] [Related]
31. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
32. Survival Rates between Early Stage Endometrial Carcinoma With or Without Para-Aortic Lymph Node Resection.
Thanagumtorn K
J Med Assoc Thai; 2016 Sep; 99(9):975-81. PubMed ID: 29927197
[TBL] [Abstract][Full Text] [Related]
33. "Malignant" uterine perivascular epithelioid cell tumor, pelvic lymph node lymphangioleiomyomatosis, and gynecological pecomatosis in a patient with tuberous sclerosis: a case report and review of the literature.
Liang SX; Pearl M; Liu J; Hwang S; Tornos C
Int J Gynecol Pathol; 2008 Jan; 27(1):86-90. PubMed ID: 18156981
[TBL] [Abstract][Full Text] [Related]
34. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin and β-catenin immunoexpression in endometrioid endometrial carcinoma.
Florescu MM; Pirici D; Simionescu CE; Stepan AE; Mărgăritescu C; Tudorache Ş; Ciurea RN
Rom J Morphol Embryol; 2016; 57(4):1235-1240. PubMed ID: 28174789
[TBL] [Abstract][Full Text] [Related]
36. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.
Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P
Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095
[TBL] [Abstract][Full Text] [Related]
38. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.
Shaco-Levy R; Sharabi S; Piura B; Sion-Vardy N
Acta Obstet Gynecol Scand; 2008; 87(8):868-74. PubMed ID: 18607832
[TBL] [Abstract][Full Text] [Related]
39. Aberrant distributions and relationships among E-cadherin, beta-catenin, and connexin 26 and 43 in endometrioid adenocarcinomas.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Lesniewicz T; Rutkowski R; Sobaniec-Lotowska M; Sulkowski S; Koda M; Sulkowska M
Int J Gynecol Pathol; 2010 Jul; 29(4):358-65. PubMed ID: 20567150
[TBL] [Abstract][Full Text] [Related]
40. Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis.
Baiocchi G; Faloppa CC; Mantoan H; Camarço WR; Badiglian-Filho L; Kumagai LY; De Brot L; da Costa AABA
J Surg Oncol; 2017 Aug; 116(2):220-226. PubMed ID: 28482122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
